Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

VMD assures market access to medicines after Brexit
The VMD has confirmed that marketing authorisation holders can continue to be based in the UK and access EU markets.
Document sets out implementation plans for life sciences

Market access to medicines during the Brexit implementation period will not change for the life science sector, the Veterinary Medicines Directorate (VMD) has confirmed.

In a document titled ‘Technical information on what the implementation period means for the life science sector’, the VMD said that marketing authorisation holders can continue to be based in the UK and access EU markets.

‘Manufacturing and distribution licences will continue to be recognised by the EU and vice versa, as will inspections,’ it continued. ‘UK based firms can continue to apply for marketing authorisations via either the centralised or decentralised procedure.’

The VMD adds that a licence for a Centrally Authorised Product (CAP) will be valid for the EU and the UK during the implementation period (29 March 2019 - 31 December 2020).

Products that have not finished a centrally authorised assessment process at the end of the implementation period may have to start again. However, this will depend upon the outcome of negotiations on the UK’s future relationship with the EU.

The assurance comes after concerns were raised by the European Medicines Agency (EMA) about how prepared marketing authorisation holders were for Brexit. A survey by the agency found that just 58 per cent of market authorisation holders for CAPs are on track with their planning for the UK’s exit from the EU.

 

Become a member or log in to add this story to your CPD history

ISFM announces first veterinary nurse conference

News Story 1
 The International Society of Feline Medicine (ISFM) - the veterinary division of International Cat Care - has announced its first annual conference dedicated to veterinary nurses. The day offers an opportunity to meet up with colleagues and enjoy more than five hours of stimulating CPD.

The conference is being held at the Crowne Plaza Hotel, Stratford-Upon-Avon, on Saturday 15 September 2018. Tickets are £95 per person and include lunch, coffee breaks, downloadable proceedings and CPD certificate. For details and to book your place visit www.eventbrite.co.uk  

Click here for more...
News Shorts
WSAVA awards Australian vet with 'Next Generation’ award

Australian vet Dr Guyan Weerasinghe has been crowned winner of the WSAVA ‘Next Generation’ Veterinary Award. The award recognises those who graduated within the last 10 years and have made a significant contribution to the welfare of companion animals and the veterinary profession as a whole.

Besides maintaining a small animal caseload, Dr Weerasinghe works for the Queensland Government’s Department of Agriculture where he is involved with animal disease surveillance and increasing the public health risks in veterinary practice. He also collaborates on various One Health projects across Australia and gives regular talks on the impact of climate change on animal health and welfare.

Dr Weerasinghe will receive his award at the WSAVA World Congress 2018 (25-28 September).